Informations sur le produit
Tenalisib is a protein inhibitor that blocks the protein kinase activity of the m2 phenotype. It has been shown to be clinically effective in treating primary T-cell lymphomas, skin cancer, and cancers of the hematopoietic system. Tenalisib inhibits the growth of cancer cells by blocking the transcriptional regulation of genes that promote cell proliferation and survival. Tenalisib is also a chemotherapeutic treatment for human macrophages and hematopoietic cells. The drug has also shown anti-tumor effects in mice with skin cancer as well as antitumor effects on human myeloid-derived suppressor cells. Tenalisib is metabolized by cytochrome P450 enzymes, which are found in high concentrations in hepatic tissue.
Propriétés chimiques
Question d’ordre technique sur : 3D-PQC41753 Tenalisib (RP6530)
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
